http://192.168.164.12:8010/index.php?title=RP11-445K13.2&feed=atom&action=historyRP11-445K13.2 - Revision history2024-03-29T15:10:44ZRevision history for this page on the wikiMediaWiki 1.30.0https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=RP11-445K13.2&diff=1274779&oldid=prevNashaiman: Created page with "==Annotation== ===Name=== RP11-445K13.2 ===Alias=== NA ===Disease=== Disease: lung adenocarcinoma [http://www.ncbi.nlm.nih.gov/pubmed/25089627 (PMID:25089627)] Dysfunction..."2018-11-05T08:52:59Z<p>Created page with "==Annotation== ===Name=== RP11-445K13.2 ===Alias=== NA ===Disease=== Disease: lung adenocarcinoma [http://www.ncbi.nlm.nih.gov/pubmed/25089627 (PMID:25089627)] Dysfunction..."</p>
<p><b>New page</b></p><div>==Annotation==<br />
===Name===<br />
RP11-445K13.2<br />
<br />
===Alias===<br />
NA<br />
<br />
===Disease===<br />
Disease: lung adenocarcinoma [http://www.ncbi.nlm.nih.gov/pubmed/25089627 (PMID:25089627)]<br />
<br />
Dysfunction type: expression<br />
<br />
Description: We initially identified a number of interesting candidate lncRNAs for further analysis. Of these, LOC100132354 and RPLP0P2 exhibited the most significantly changed expression in our analysis of 100 pairs of lung adenocarcinoma and normal lung tissue samples. The expression of LOC100132354 was significantly higher in lung adenocarcinoma than in the adjacent tissues, while the expression of RPLP0P2 was significantly lower in lung adenocarcinoma than in the adjacent tissues.<br />
<br />
<br />
===Function===<br />
Function Mechanism: NA [http://www.ncbi.nlm.nih.gov/pubmed/25089627 (PMID:25089627)]<br />
<br />
Biological Process: pathogenic process<br />
<br />
Description: NA</div>Nashaiman